B. Giroir

发表

IκB overexpression in cardiomyocytes prevents NF-κB translocation and provides cardioprotection in trauma

D. Carlson, D. White, D. Maass, 2003 .

Complementary DNA (cDNA) sequence of baboon tumor necrosis factor alpha.

H. Redl, G. Schlag, B. Giroir, 1997, Molecular immunology.

Sequence Analysis of the Tumor Necrosis Factor Gene in Pediatric Patients with Autoimmunity

B. Giroir, L. Becker, T. Brown, 1995, Pediatric Research.

A reporter transgene indicates renal-specific induction of tumor necrosis factor (TNF) by shiga-like toxin. Possible involvement of TNF in hemolytic uremic syndrome.

B. Beutler, B. Giroir, M. Silva, 1993, The Journal of clinical investigation.

The systemic inflammatory response syndrome (SIRS): Immunology and potential immunotherapy

B. Giroir, T. Darville, R. Jacobs, 1993, Infection.

The tissue distribution of tumor necrosis factor biosynthesis during endotoxemia.

J. H. Johnson, B. Beutler, B. Giroir, 1992, The Journal of clinical investigation.

International pediatric sepsis consensus conference: Definitions for sepsis and organ dysfunction in pediatrics*

A. Randolph, B. Goldstein, B. Giroir, 2005, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

Constitutive synthesis of tumor necrosis factor in the thymus.

B. Beutler, B. Giroir, T. Brown, 1992, Proceedings of the National Academy of Sciences of the United States of America.

Pediatric critical care medicine: Planning for our research future

John Whyte, Carol E. Nicholson, Jerry J Zimmerman, 2003, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

Recombinant human activated protein C for the treatment of severe sepsis: is there a role in pediatrics?

B. Giroir, 2003, Current opinion in pediatrics.

Genetic sequences and transcriptional regulation of the TNFA promoter: comparison of human and baboon

H. Redl, G. Schlag, B. Giroir, 1998, Immunogenetics.

Bactericidal/Permeability-Increasing Protein (BPI): Structure, Function, and Clinical Applications

B. Giroir, S. Carroll, P. Scannon, 1998 .

Pathophysiology, treatment and outcome of meningococcemia: a review and recent experience.

B. Giroir, L. Kitchen, E. A. Kirsch, 1996, The Pediatric infectious disease journal.

IRAK1 deletion disrupts cardiac Toll/IL-1 signaling and protects against contractile dysfunction.

D. Kusewitt, D. White, B. Giroir, 2003, American journal of physiology. Heart and circulatory physiology.

Ending the HIV Epidemic: A Plan for the United States.

R. Redfield, A. Fauci, B. Giroir, 2019, JAMA.

Cytokine-induced expression of nitric oxide synthase in C2C12 skeletal muscle myocytes.

B. Giroir, L. Becker, T. Brown, 1994, The American journal of physiology.

Factor-Cardiac Failure in Transgenic Mice With Myocardial Expression of Tumor Necrosis

R. Peshock, J. Shelton, B. Giroir, 1998 .

Tumor necrosis factor-α-induced caspase activation mediates endotoxin-related cardiac dysfunction*

D. Carlson, D. White, B. Giroir, 2005, Critical care medicine.

BURN PLASMA MEDIATES CARDIAC MYOCYTE APOPTOSIS VIA ENDOTOXIN: 96

E. Lightfoot, D. Carlson, D. Maass, 2001 .

Bactericidal/permeability-increasing protein—Lessons learned from the phase III, randomized, clinical trial of rBPI21 for adjunctive treatment of children with severe meningococcemia

M. Levin, B. Giroir, P. Scannon, 2001, Critical care medicine.

Bactericidal/permeability-increasing protein: clinical development and potential pediatric applications.

B. Giroir, 2001, The Pediatric infectious disease journal.

Thermal injury alters myocardial sarcoplasmic reticulum calcium channel function.

B. Giroir, J. Horton, J. Murphy, 1999, The Journal of surgical research.

Burn plasma mediates cardiac myocyte apoptosis via endotoxin.

E. Lightfoot, D. Carlson, D. Maass, 2001, American journal of physiology. Heart and circulatory physiology.

Myocardial inflammatory activation in children with congenital heart disease

B. Giroir, S. Haudek, S. Leonard, 2002, Critical care medicine.

Differential Regulation of Myocardial NF κ B Following Acute or Chronic TNF- α Exposure

B. Giroir, S. Haudek, D. Bryant, 2001 .

Overexpression of cardiac I-κBα prevents endotoxin-induced myocardial dysfunction

Zhijian J. Chen, E. Spencer, D. White, 2001 .

Randomized, placebo-controlled, double blinded trial of dexamethasone in African children with sepsis.

C. Howard, T. Slusher, B. Giroir, 1996, The Pediatric infectious disease journal.

Molecular and pharmacological approaches to inhibiting nitric oxide after burn trauma.

D. Carlson, D. Maass, B. Giroir, 2003, American journal of physiology. Heart and circulatory physiology.

Preoperative and postoperative endotoxemia in children with congenital heart disease.

B. Giroir, S. Leonard, P. Scannon, 2000, Chest.

Increased Cardiomyocyte Intracellular Calcium during Endotoxin-Induced Cardiac Dysfunction in Guinea Pigs

D. White, D. Maass, B. Giroir, 2000, Pediatric Research.

Inhibition of tumor necrosis factor prevents myocardial dysfunction during burn shock.

D. White, B. Giroir, J. Horton, 1994, The American journal of physiology.

Myocardial depression versus myocardial destruction: integrating the multiple mechanisms of myocardial dysfunction during sepsis.

B. Giroir, D. Stromberg, 2000, Critical care medicine.

Aspiration pneumonia-induced sepsis increases cardiac dysfunction after burn trauma.

D. White, D. Maass, B. Giroir, 1998, The Journal of surgical research.

Usefulness of external counterpulsation early postoperatively after the Fontan procedure in children.

B. Giroir, M. Lemler, S. Leonard, 2002, The American journal of cardiology.

Obesity, macrophage migration inhibitory factor, and weight loss

T. Church, D. Wilson, C. Earnest, 2005, International Journal of Obesity.

Nucleoside-specific suppression in MRL/MP +/+ mice.

B. Giroir, E. Raps, R. Lewis, 1983, Cellular immunology.

Preliminary evaluation of recombinant amino-terminal fragment of human bactericidal/permeability-increasing protein in children with severe meningococcal sepsis

B. Giroir, S. Carroll, P. Scannon, 1997, The Lancet.

Effect of amrinone on tumor necrosis factor production in endotoxic shock.

B. Beutler, B. Giroir, 1992, Circulatory shock.

Magnetic resonance imaging and invasive evaluation of development of heart failure in transgenic mice with myocardial expression of tumor necrosis factor-alpha.

R. Peshock, B. Giroir, R. Victor, 1999, Circulation.

Macrophage migration inhibitory factor mediates late cardiac dysfunction after burn injury.

J. DiMaio, D. Carlson, D. White, 2005, American journal of physiology. Heart and circulatory physiology.

MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF) MEDIATES LATE CARDIAC DYSFUNCTION FOLLOWING THERMAL INJURY: 320

D. Carlson, B. Giroir, J. Horton, 2004 .

Erratum: IRAK1 deletion disrupts cardiac Toll/IL-1 signaling and protects against contractile dysfunction (American Journal of Physiology Heart and Circulatory Physiology (August 2003) 285 (H597-H606))

A. James, D. Kusewitt, D. White, 2004 .

Differential regulation of myocardial NF kappa B following acute or chronic TNF-alpha exposure.

B. Giroir, S. Haudek, D. Bryant, 2001, Journal of molecular and cellular cardiology.

Antioxidant vitamin therapy alters burn trauma-mediated cardiac NF-kappaB activation and cardiomyocyte cytokine secretion.

D. White, D. Maass, B. Giroir, 2001, The Journal of trauma.

Racial/Ethnic and Age Group Differences in Opioid and Synthetic Opioid–Involved Overdose Deaths Among Adults Aged ≥18 Years in Metropolitan Areas — United States, 2015–2017

Christopher M. Jones, E. Olsen, B. Giroir, 2019, MMWR. Morbidity and mortality weekly report.

Macrophage migration inhibitory factor is a cardiac-derived myocardial depressant factor.

J. DiMaio, D. Carlson, D. White, 2003, American journal of physiology. Heart and circulatory physiology.

Chapter 83 – The Innate Immune System

B. Giroir, 2006 .

Fresh whole blood versus reconstituted blood for pump priming in heart surgery in infants.

B. Giroir, S. Leonard, D. Stromberg, 2004, The New England journal of medicine.

Human coronary endothelial cell activation by endotoxin is characterized by NF-κB activation and TNF-α synthesis

B. Giroir, S. Haudek, Joseph T. Murphy, 2001 .

Hemodynamic effects of i.v. milrinone lactate in pediatric patients with septic shock. A prospective, double-blinded, randomized, placebo-controlled, interventional study.

S. Lawless, B. Giroir, A. Kouatli, 1996, Chest.

Septic Shock in Children: When Should Prevention Start and Treatment End?

B. Giroir, Shahla M. Jilani, 2020, Critical care medicine.

Molecular biology of septic shock.

B. Giroir, S. Haudek, M. Thompson, 1998, New horizons.

Regulation of cytokine gene expression: tumor necrosis factor, interleukin-1, and the emerging biology of cytokine receptors.

B. Giroir, G. Williams, 1995, New horizons.

Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-alpha.

R. Peshock, J. Shelton, B. Giroir, 1998, Circulation.

Effects of transforming growth factor-beta 1 on nitric oxide synthesis by C2C12 skeletal myocytes.

B. Giroir, L. Becker, D. Bryant, 1996, The American journal of physiology.

Mediators of septic shock: New approaches for interrupting the endogenous inflammatory cascade

B. Giroir, 1993, Critical care medicine.

Meningococcemia as a model for testing the hypothesis of antisepsis therapies

B. Giroir, 2000, Critical care medicine.

Development of an acute burn model in adult mice for studies of cardiac function and cardiomyocyte cellular function.

D. Maass, B. Giroir, J. Horton, 2001, Shock.

Calcium antagonists improve cardiac mechanical performance after thermal trauma.

D. White, D. Maass, B. Giroir, 1999, The Journal of surgical research.

Patient-Centered Reduction or Discontinuation of Long-term Opioid Analgesics: The HHS Guide for Clinicians.

W. Compton, B. Giroir, Deborah Dowell, 2019, JAMA.

The biosynthesis of tumor necrosis factor during pregnancy: studies with a CAT reporter transgene and TNF inhibitors.

B. Beutler, B. Giroir, M. Silva, 1992, European cytokine network.

Pharmacokinetics and pharmacodynamics of milrinone lactate in pediatric patients with septic shock.

S. Lawless, B. Giroir, A. Kouatli, 1998, The Journal of pediatrics.

Tumor Necrosis Factor: The molecules and Their Emerging Role in Medicine

B. Beutler, V. Kruys, B. Giroir, 1992 .

Cell lines derived from avian lymphomas exhibit two distinct phenotypes.

B. Giroir, E. H. Humphries, T. Baba, 1985, Virology.

The Pediatric Multiple Organ Dysfunction Score (P-MODS): Development and validation of an objective scale to measure the severity of multiple organ dysfunction in critically ill children*

B. Giroir, A. L. Graciano, J. A. Balko, 2005, Critical care medicine.

ENHANCE: Results of a global open-label trial of drotrecogin alfa (activated) in children with severe sepsis*

Mark D. Williams, B. Giroir, M. Peters, 2006, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

Pancreatitis, cytokines, and SIRS: déjà vu all over again?

B. Giroir, 1999, Critical Care Medicine.

What Are the Specific Definitions of Pediatric SIRS , Infection , Sepsis , Severe Sepsis , and Septic Shock ?

A. Randolph, B. Giroir, B. Goldstein, 2005 .

H-2-determined kinetic differences for the induction of nucleoside-specific suppression.

B. Giroir, E. Raps, E. Cookson, 1983, Cellular immunology.

Improving the outcome of septic shock in children.

B. Giroir, E. A. Kirsch, 2000, Current opinion in infectious diseases.

Clinical expert round table discussion (session 5) at the Margaux Conference on Critical Illness: outcomes of clinical trials in sepsis: lessons learned.

D. Annane, G. Bernard, J. Vincent, 2001, Critical care medicine.

Recombinant bactericidal/permeability-increasing protein (rBPI21) as adjunctive treatment for children with severe meningococcal sepsis: a randomised trial

Phil Barton, Brahm Goldstein, Michael Levin, 2000, The Lancet.